The 2007 American Heart Association (AHA) guidelines limited antibiotic prophylaxis (AP) for infective endocarditis (IE) to fewer patients with predisposing cardiac conditions (PCC). We surveyed the American Academy of Pediatrics Section on Cardiology and Cardiac Surgery (AAP SOCCS) on their recommendations for AP for a number of PCC and procedures. We report on those 173 respondents who follow the 2007 AHA guidelines. AP rates for high-risk PCCs clearly meeting AHA criteria ranged from 70.5-89.8%. Conversely, for PCCs which did not meet AHA criteria, prescribing rates varied from <1% to 29.5%. PCC for which AP indication was unclear per guidelines, AP rates similarly varied from 9.9-39.8%. Similar variability is noted in AP for various procedures in setting of high-risk PCC. There is variability in AP prescribing practices among pediatric cardiologists based on both underlying PCC and noncardiac procedures in the setting of underlying cardiac disease.
JonesTDBaumgartnerLBellowsMT, et al. Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Circulation. 1955;11:317-320.
2.
WilsonWTaubertKAGewitzM, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007;138(6):739-745, 747-760. doi:10.14219/jada.archive.2007.0262.
3.
HabibGHoenBTornosP, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30(19):2369-2413. doi:10.1093/eurheartj/ehp285.
4.
National Institute for Health and Clinical Excellence. Prophylaxis against infective endocarditis 2008. NICE clinical guideline no. 64. Accessed June 14, 2022. www.nice.org.uk/CG064.
5.
NaikRJPatelNRWangMShahNC. Infective endocarditis prophylaxis: current practice trend among paediatric cardiologists: are we following the 2007 guidelines?Cardiol Young. 2016;26(6):1176-1182. doi:10.1017/S1047951115002176.
6.
PatelJKupfermanFRapaportSKernJH. Preprocedure prophylaxis against endocarditis among United States pediatric cardiologists. Pediatr Cardiol. 2014;35(7):1220-1224. doi:10.1007/s00246-014-0919-1.
7.
PharisCSConwayJWarrenAEBullockAMackieAS. The impact of 2007 infective endocarditis prophylaxis guidelines on the practice of congenital heart disease specialists. Am Heart J. 2011;161(1):123-129. doi:10.1016/j.ahj.2010.09.024.
8.
ShahNCPatelNNaikR. Infective endocarditis prophylaxis-current practice amongst pediatric cardiologists: are we following 2007 guidelines?JACC. 2014;63(12):A602.
9.
AnguitaPCastilloFGámezP, et al. Behaviour of health professionals concerning the recommendations for prophylaxis for infectious endocarditis in our setting: are the guidelines followed?Rev Clin Esp (Barc). 2017;217(2):79-86. doi:10.1016/j.rce.2016.10.005.
10.
DayerMJChambersJBPrendergastBSandoeJAThornhillMH. NICE guidance on antibiotic prophylaxis to prevent infective endocarditis: a survey of clinicians’ attitudes. QJM. 2013;106(3):237-243. doi:10.1093/qjmed/hcs235.
11.
FarookSADavisAKKhawajaNSheikhAM. NICE guideline and current practice of antibiotic prophylaxis for high risk cardiac patients (HRCP) among dental trainers and trainees in the United Kingdom (UK). Br Dent J. 2012;213(4):E6. doi:10.1038/sj.bdj.2012.723.
12.
GrattanMJPowerAFruitmanDSIslamSMackieAS. The impact of infective endocarditis prophylaxis recommendations on the practices of pediatric and adult congenital cardiologists. Can J Cardiol. 2015;31(12):1497.e23-1497.e28. doi:10.1016/j.cjca.2015.04.032.
13.
JainPStevensonTSheppardA, et al. Antibiotic prophylaxis for infective endocarditis: knowledge and implementation of American Heart Association guidelines among dentists and dental hygienists in Alberta, Canada. J Am Dent Assoc. 2015;146(10):743-750. doi:10.1016/j.adaj.2015.03.021.
14.
LockhartPBHansonNBRisticHMenezesARBaddourL. Acceptance among and impact on dental practitioners and patients of American Heart Association recommendations for antibiotic prophylaxis. J Am Dent Assoc. 2013;144(9):1030-1035.
15.
SpittleLSMuzzinKBCampbellPRDeWaldJPRivera-HidalgoF. Current prescribing practices for antibiotic prophylaxis: a survey of dental practitioners. J Contemp Dent Pract. 2017;18(7):559-566.
16.
TongHJHuSMokBYIslamIHongCH. Antibiotic prophylaxis prescribing practices of dentists in Singapore. Int Dent J. 2014;64(2):108-114. doi:10.1111/idj.12088.
17.
ZadikYFindlerMLivneSLevinLEladS; American Heart Association. Dentists’ knowledge and implementation of the 2007 American Heart Association guidelines for prevention of infective endocarditis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106(6):e16-e19. doi:10.1016/j.tripleo.2008.08.009.
18.
DeSimoneDCEl RafeiAChallenerDW, et al. Effect of the American Heart Association 2007 guidelines on the practice of dental prophylaxis for the prevention of infective endocarditis in Olmsted County, Minnesota. Mayo Clin Proc. 2017. doi:10.1016/j.mayocp.2017.03.013.
19.
EladSBinenfeld-AlonEZadikYAharoniMFindlerM. Survey of acceptance of the 2007 American Heart Association guidelines for the prevention of infective endocarditis: a pilot study. Quintessence Int. 2011;42(3):243-251.
20.
LauberCLalhSSGraceM, et al. Antibiotic prophylaxis practices in dentistry: a survey of dentists and physicians. J Can Dent Assoc. 2007;73(3):245.
21.
BatesKEHallMShahSSHillKDPasqualiSK. Trends in infective endocarditis hospitalisations at United States children’s hospitals from 2003 to 2014: impact of the 2007 American Heart Association antibiotic prophylaxis guidelines. Cardiol Young. 2017;27(4):686-690. doi:10.1017/S1047951116001086.
22.
BikdeliBWangYKimNDesaiMMQuagliarelloVKrumholzHM. Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol. 2013;62(23):2217-2226. doi:10.1016/j.jacc.2013.07.071.
23.
DesimoneDCTleyjehIMCorrea de SaDD, et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation. 2012;126(1):60-64. doi:10.1161/CIRCULATIONAHA.112.095281.
24.
DeSimoneDCTleyjehIMCorrea de SaDD, et al. Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN. Am Heart J. 2015;170(4):830-836. doi:10.1016/j.ahj.2015.07.007.
25.
DeSimoneDCTleyjehIMCorrea de SaDD, et al. Incidence of infective endocarditis due to viridans group streptococci before and after the 2007 American Heart Association’s prevention guidelines: an extended evaluation of the Olmsted County, Minnesota, population and nationwide inpatient sample. Mayo Clin Proc. 2015;90(7):874-881. doi:10.1016/j.mayocp.2015.04.019.
26.
DeSimoneDCWilsonWRBaddourLM. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011: the devil is in the details. J Am Coll Cardiol. 2015;66(10):1201-1202. doi:10.1016/j.jacc.2015.05.079.
27.
DuvalXDelahayeFAllaF, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59(22):1968-1976. doi:10.1016/j.jacc.2012.02.029.
28.
GargPKoDTBray JenkynKMLiLShariffSZ. Infective endocarditis hospitalizations and antibiotic prophylaxis rates before and after the 2007 American Heart Association guideline revision. Circulation. 2019;140(3):170-180. doi:10.1161/CIRCULATIONAHA.118.037657.
29.
KellerKvon BardelebenRSOstadMA, et al. Temporal trends in the prevalence of infective endocarditis in Germany between 2005 and 2014. Am J Cardiol. 2017;119(2):317-322. doi:10.1016/j.amjcard.2016.09.035.
30.
MackieASLiuWSavuAMarelliAJKaulP. Infective endocarditis hospitalizations before and after the 2007 American Heart Association prophylaxis guidelines. Can J Cardiol. 2016;32(8):942-948. doi:10.1016/j.cjca.2015.09.021.
31.
PantSPatelNJDeshmukhA, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65(19):2070-2076. doi:10.1016/j.jacc.2015.03.518.
32.
PasqualiSKHeXMohamadZ, et al. Trends in endocarditis hospitalizations at US children’s hospitals: impact of the 2007 American Heart Association antibiotic prophylaxis guidelines. Am Heart J. 2012;163(5):894-899. doi:10.1016/j.ahj.2012.03.002.
33.
RogersAMSchillerNB. Impact of the first nine months of revised infective endocarditis prophylaxis guidelines at a university hospital: so far so good. J Am Soc Echocardiogr. 2008;21(6):775. doi:10.1016/j.echo.2008.04.001.
34.
RushaniDKaufmanJSIonescu-IttuR, et al. Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors. Circulation. 2013;128(13):1412-1419. doi:10.1161/CIRCULATIONAHA.113.001827.
35.
Sakai BizmarkRChangRRTsugawaYZangwillKMKawachiI. Impact of AHA’s 2007 guideline change on incidence of infective endocarditis in infants and children. Am Heart J. 2017;189:110-119. doi:10.1016/j.ahj.2017.04.006.
36.
ThornhillMH. Infective endocarditis: the impact of the NICE guidelines for antibiotic prophylaxis. Dent Update. 2012;39(1):6-10. doi:10.12968/denu.2012.39.1.6.
ThornhillMHDayerMJFordeJM, et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011;342:d2392. doi:10.1136/bmj.d2392.
39.
ThornhillMHDayerMJJonesSPrendergastBBaddourLMLockhartPB. The effect of antibiotic prophylaxis guidelines on incidence of infective endocarditis. Can J Cardiol. 2016;32(12):1578e9. doi:10.1016/j.cjca.2016.02.074.
40.
ThornhillMHGibsonTBCutlerE, et al. Antibiotic prophylaxis and incidence of endocarditis before and after the 2007 AHA recommendations. J Am Coll Cardiol. 2018;72(20):2443-2454. doi:10.1016/j.jacc.2018.08.2178.
41.
TubianaSBlotierePOHoenB, et al. Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study. BMJ. 2017;358:j3776. doi:10.1136/bmj.j3776.
42.
van den BrinkFSSwaansMJHoogendijkMG, et al. Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands. Eur Heart J Qual Care Clin Outcomes. 2017;3(2):141-147. doi:10.1093/ehjqcco/qcw039.
43.
DolgnerSJAryaBKronmanMPChanT. Effect of congenital heart disease status on trends in pediatric infective endocarditis hospitalizations in the United States between 2000 and 2012. Pediatr Cardiol. 2019;40(2):319-329. doi:10.1007/s00246-018-2020-7.
44.
Malekzadeh-MilaniSLadouceurMIserinLBonnetDBoudjemlineY. Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation. J Thorac Cardiovasc Surg. 2014;148(5):2253-2259. doi:10.1016/j.jtcvs.2014.07.097.
45.
Malekzadeh-MilaniSLadouceurMPatelM, et al. Incidence and predictors of Melody® valve endocarditis: a prospective study. Arch Cardiovasc Dis. 2015;108(2):97-106. doi:10.1016/j.acvd.2014.09.003.
46.
McElhinneyDBBensonLNEickenAKreutzerJPaderaRFZahnEM. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6(3):292-300. doi:10.1161/CIRCINTERVENTIONS.112.000087.
47.
GersonyWMHaynesCJDriscollDJ, et al. Report from the second joint study on the natural history of congenital heart defects (NHS-2): bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. 1993;87(2S):121-126.
48.
MichelenaHIKatanOSuriRMBaddourLMEnriquez-SaranoM. Incidence of infective endocarditis in patients with bicuspid aortic valves in the community. Mayo Clin Proc. 2016;91(1):122-123. doi:10.1016/j.mayocp.2015.10.011.
49.
LeTGrahamNJNaeemA, et al. Aortic valve endocarditis in patients with bicuspid and tricuspid aortic valves. JTCVS Open. 2021;8:228-236. doi:10.1016/j.xjon.2021.09.007.
50.
ShishegarMAshrafMJ. Posttonsillectomy bacteremia and comparison of tonsillar surface and deep culture. Adv Prev Med. 2014;2014:161878. doi:10.1155/2014/161878.
51.
KocSGürbüzlerLYenişehirliG, et al. The comparison of bacteremia and amount of bleeding during adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2011;75(1):12-14. doi:10.1016/j.ijporl.2010.09.009.
52.
KocaturkSYildirimADemirayTBaharGBakiciMZ. Cold dissection versus bipolar cauterizing tonsillectomy for bacteremia. Am J Otolaryngol. 2005;26(1):61-63.
53.
YildirimIOkurECiragilPAralMKilicMAGulM. Bacteraemia during tonsillectomy. J Laryngol Otol. 2003;117:619-623.
54.
KaygusuzIGökUYalcinSKelesEKizirgilADemirbagE. Bacteremia during tonsillectomy. Int J Pediatr Otorhinolaryngol. 2001;58:69-73.
55.
Siegman-IgraY. Infective endocarditis following gastrointestinal and genitourinary procedures: an argument in favour of prophylaxis. Scand J Infect Dis. 2010;42(3):208-214. doi:10.3109/00365540903443140.
56.
TseDMKhanSClarkeS. Bacterial endocarditis and body art: active prevention or antibiotic prophylaxis. Int J Cardiol. 2018;139(3):297-298. doi:10.1016/j.ijcard.2008.08.002.
57.
ArmstrongMLDeBoerSCettaF. Infective endocarditis after body art: a review of the literature and concerns. J Adolesc Health. 2008;43(3):217-225.
58.
NahSChungMParkJEDureyAKimMLeeJ. Infective endocarditis caused by methicillin-resistant Staphyloccocus aureus in a young woman after ear piercing: a case report. J Med Case Rep. 2001;5:336.
59.
FriedelJMStehlikJDesaiMGranatoJE. Infective endocarditis after oral body piercing. Cardiol Rev. 2003;11(5):252-255.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
